D: Filing D
10-Q: Quarterly report
8-K: Cyclacel Pharmaceuticals Reports first quarter financial results and provides business update
EFFECT: Others
424B3: Prospectus
ARS: Annual Report to Security Holders
DEFA14A: Others
DEF 14A: Definitive information statements
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
RW: Registration Withdrawal Request
10-K/A: Annual report (Amendment)
8-K: Current report
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Cyclacel Pharmaceuticals | 8-K: Current report
Cyclacel Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Cyclacel Pharmaceuticals | 10-K: Annual report
Cyclacel Pharmaceuticals | 8-K: Cyclacel Pharmaceuticals Reports fourth quarter and full year 2023 financial results and provides business update
Cyclacel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Schonfeld Strategic Advisors LLC(0.18%)
No Data